Clinical Trial

Pilot Study on HA380 Column Use in Critically Ill Patients Receiving Extracorporeal Support.

Study acronym: HACEC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 2, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Patients who are very ill either due to a severe infection, major organ injury, trauma or a major operation may require significant support with devices such as a dialysis machine for the kidneys or Extracorporeal Membrane Oxygenation (ECMO) for the heart and lungs. This is often due to a reaction of the body to the insult which is termed inflammation. The investigators would like to assess if the use of a device that can remove the agents driving this reaction can lead to a quicker recovery form the illness. The device is a blood filter called HA380 and it would be connected to either the dialysis machine or the ECMO circuit. The investigators want to assess the feasibility of conducting a study with the HA380 column. We will also evaluate if the use of the HA380 column has an effect on the time spent on dialysis or ECMO, time spent on the breathing machine, time spent requiring drugs to support blood pressure and time spent in the intensive care unit.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-12-11; most recent amendment 2026-02-27.
Status change: Not Yet Recruiting → Recruiting 2025-03-25
Trial Details
NCT Number NCT06179771
Lead Sponsor University Hospitals, Leicester
Conditions Acute Kidney Injury, ARDS, Inflammation, Extracorporeal Circulation; Complications
Enrollment 40 participants
Start Date 2024-09-02
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-02